Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RONALD L FELLMAN

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1780626226
CMS profile
81206
Location
DALLAS, TX

General Payments · PY2018–2024

$29,040.62

  • Reported across 103 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$376.40

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $376.40 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $258.98 11
GLAUKOS CORPORATION $52.66 1
Bausch & Lomb Americas Inc. $24.91 1
BIOTISSUE HOLDINGS INC. $23.61 1
Alcon Laboratories Inc $16.24 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,435.36 17
PY2019 $11,587.23 20
PY2020 $6,107.78 7
PY2021 $4,782.85 8
PY2022 $443.83 16
PY2023 $1,307.17 20
PY2024 $376.40 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.27 01/30/2024 Food and Beverage Undisputed 01/23/2026 1103719472 CMS
ABBVIE INC. $25.67 03/08/2024 Food and Beverage Undisputed 01/23/2026 1103719474 CMS
ABBVIE INC. $27.88 03/11/2024 Food and Beverage Undisputed 01/23/2026 1103719476 CMS
ABBVIE INC. $30.29 03/29/2024 Food and Beverage Undisputed 01/23/2026 1103719478 CMS
ABBVIE INC. $21.39 07/02/2024 Food and Beverage Undisputed 01/23/2026 1103719480 CMS
ABBVIE INC. $26.99 07/25/2024 Food and Beverage Undisputed 01/23/2026 1103719482 CMS
ABBVIE INC. $27.65 08/22/2024 Food and Beverage Undisputed 01/23/2026 1103719484 CMS
ABBVIE INC. $4.68 09/17/2024 Food and Beverage Undisputed 01/23/2026 1103719486 CMS
ABBVIE INC. $25.60 10/31/2024 Food and Beverage Undisputed 01/23/2026 1103719488 CMS
ABBVIE INC. $21.21 12/16/2024 Food and Beverage Undisputed 01/23/2026 1103719490 CMS
ABBVIE INC. $30.35 12/20/2024 Food and Beverage Undisputed 01/23/2026 1103719492 CMS
Alcon Vision LLC $16.24 04/25/2024 Food and Beverage Undisputed 01/23/2026 1110565913 CMS
Bausch & Lomb Americas Inc. $24.91 02/06/2024 Food and Beverage Undisputed 01/23/2026 1140438128 CMS
BIOTISSUE HOLDINGS INC. $23.61 09/16/2024 Food and Beverage Undisputed 01/23/2026 1148764110 CMS
Glaukos Corporation $52.66 11/12/2024 Food and Beverage Undisputed 01/23/2026 1151989206 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.